INSM1 and breast carcinoma: A study by Roy et al. found that INSM1 was diffusely expressed in five out of seven breast carcinoma cases with neuroendocrine differentiation (similar to CgA and CD56 expression) while SYP was expressed in six of the seven cases [59].